Researchers at a university used cryo-EM to study how the T cell receptor (TCR) begins signalling that leads to cancer cell killing. The work aimed to explain why current T cell immunotherapies work for some cancer subtypes but not others. The team found the receptor in a closed, compact state when resting and observed it open and extend when it encountered an antigen-presenting molecule.
The group made two key methodological changes. They returned the multi-protein complex to a membrane using nanodiscs and chose a lipid mixture that resembled the native T cell membrane. Getting all eight proteins properly assembled into the nanodisc was difficult. Earlier studies used detergent, which removed the membrane and apparently left the receptor in an open state even when dormant.
Lead researchers said the new structural view could help refine and expand T cell therapies. They suggested it might be possible to re-engineer receptor sensitivity and tune activation thresholds for adoptive T cell therapies used in some rare sarcomas. The structures could also inform vaccine design and allow others to study detailed interactions between HLA-presented antigens and T cell receptors.
Difficult words
- receptor — protein on a cell that detects signalsT cell receptor
- membrane — thin layer around cells or cell partsT cell membrane
- antigen — substance that triggers immune response in bodyantigens
- assemble — to put parts together to make wholeassembled
- detergent — chemical used to remove oils and fats
- sensitivity — how easily something reacts to a signal
- nanodisc — small artificial piece of membrane for studynanodiscs
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- How might changing receptor sensitivity affect T cell therapy for patients?
- What challenges do you think scientists face when assembling eight proteins into a nanodisc?
- How could detailed structures of T cell receptors and HLA-presented antigens help vaccine design?
Related articles
Aging muscle may help cancer grow
Scientists found that older, weaker muscle releases fewer extracellular vesicles and less of a microRNA called miR-7a-5p. Exercise can restore vesicle release and may help reduce cancer risk in older adults. The work suggests new biomarkers and therapies.
Egyptian university and pharma join to create Africa’s first biotechnology academy
The American University in Cairo and Minapharm have formed a partnership to set up what the university calls the first African academy for biotechnology. The initiative starts early this year to strengthen education, research and industry links.
Cherry compounds may slow triple-negative breast cancer
Researchers at Texas A&M report that anthocyanins from dark sweet cherries slowed tumour growth and reduced metastasis in mice, and that combining them with chemotherapy helped control tumours. Further research is needed on safety and absorption.